BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18019407)

  • 1. Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.
    Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Patsouris E
    In Vivo; 2007; 21(5):745-50. PubMed ID: 18019407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
    Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
    Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
    Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
    Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes increases both N-ras and ets-1 expression during rat oral oncogenesis resulting in enhanced cell proliferation and metastatic potential.
    Vairaktaris E; Goutzanis L; Kalokerinos G; Yannopoulos A; Yapijakis C; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris AC; Tesseromatis C; Patsouris E
    In Vivo; 2007; 21(4):615-21. PubMed ID: 17708355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Goutzanis L; Vylliotis A; Lazaris A; Donta I; Perrea D; Yapijakis C; Patsouris E
    Anticancer Res; 2007; 27(6B):4185-93. PubMed ID: 18225590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hamster model of sequential oral oncogenesis.
    Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
    Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p16 in oral cancer and premalignant lesions.
    Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
    J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
    Tokman B; Gultekin SE; Sezer C; Alpar R
    Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway.
    Vairaktaris E; Goutzanis L; Kalokerinos G; Vassiliou S; Spyridonidou S; Avgoustidis D; Strantzias P; Lazaris A; Papageorgiou G; Ragos V; Yapijakis C; Patsouris E
    J Craniomaxillofac Surg; 2007 Dec; 35(8):382-7. PubMed ID: 18023197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes enhances cell proliferation but not Bax/Bcl-2-mediated apoptosis during oral oncogenesis.
    Vairaktaris E; Kalokerinos G; Goutzanis L; Yapijakis C; Derka S; Vassiliou S; Spyridonidou S; Vylliotis A; Nkenke E; Lazaris A; Patsouris E
    Int J Oral Maxillofac Surg; 2008 Jan; 37(1):60-5. PubMed ID: 17825529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors.
    Vairaktaris E; Goutzanis L; Nkenke E; Spyridonidou S; Vassiliou S; Derka S; Vylliotis A; Yapijakis C; Lazaris A; Strantzias P; Kalimeras E; Patsouris E
    In Vivo; 2007; 21(4):623-8. PubMed ID: 17708356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
    Liu HW; Hu BQ; Cao CF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
    Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
    Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway.
    Goutzanis L; Vairaktaris E; Yapijakis C; Kavantzas N; Nkenke E; Derka S; Vassiliou S; Acil Y; Kessler P; Stavrianeas N; Perrea D; Donta I; Skandalakis P; Patsouris E
    Oral Oncol; 2007 Feb; 43(2):165-73. PubMed ID: 16860589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-expression of c-myc and p53 increases and reaches a plateau early in oral oncogenesis.
    Papakosta V; Vairaktaris E; Vylliotis A; Derka S; Nkenke E; Vassiliou S; Lazaris A; Mourouzis C; Rallis G; Spyridonidou S; Anagnostopoulou S; Perrea D; Donta I; Yapijakis C; Patsouris E
    Anticancer Res; 2006; 26(4B):2957-62. PubMed ID: 16886620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
    Angadi PV; Krishnapillai R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-ras and c-fos exhibit similar expression patterns during most stages of oral oncogenesis.
    Vairaktaris E; Papakosta V; Derka S; Vassiliou S; Nkenke E; Spyridonidou S; Vylliotis A; Lazaris A; Kokkori A; Moulavassili P; Loukeri S; Perrea D; Donta I; Yapijakis C; Patsouris E
    In Vivo; 2008; 22(5):621-8. PubMed ID: 18853758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The relationship between methylation of p16 INK 4/CDKN2 gene in promoter region and progress of squamous cell carcinoma of buccal mucosa].
    Dong YY; Wang J; Dong FS; Wang X; Li HX; Gu HT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 May; 41(5):297-8. PubMed ID: 16784614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.